TP53 hotspot mutations are predictive of survival in primary central nervous system lymphoma patients treated with combination chemotherapy.
| Autor: | Munch-Petersen, Helga D.1,2, Asmar, Fazila1, Dimopoulos, Konstantinos1, Areškevièiute, Aušrine2, Brown, Peter1, Girkov, Mia Seremet1, Pedersen, Anja1, Sjö, Lene D.2, Heegaard, Steffen2,3, Broholm, Helle2, Kristensen, Lasse S.1, Ralfkiaer, Elisabeth2, Grønbæk, Kirsten1 kirsten.groenbaek@regionh.dk |
|---|---|
| Zdroj: | Acta Neuropathologica Communications. 4/22/2016, Vol. 4, p1-13. 13p. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|